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The need to control bleeding and wound healing presents a significant clinical 
need in surgery, trauma, and emergency medicine. Fibrin is the body’s natural 
provisional matrix activated in response to vascular injury, and fails in traumatic 
hemorrhaging due to mass dilution effects, the inability to concentrate clotting factors, 
and failure to generate tissue compressive forces. Noncovalent knob:hole interactions 
between fibrin monomers are critical for the assembly of fibrin that leads to network and 
clot formation. In this study we aimed to exploit fibrin knob:hole affinity interactions 
with swelling, space filling microgels for the development of a robust bio-synthetic 
hybrid polymer system with superior hemostatic properties. Previous work has explored 
the inherent binding interactions of various fibrin knobs and their complementary 
polymerization holes, which have led to the development of fibrin knob peptide mimic 
(GPRPFPAC) with enhanced binding affinity for fibrin(ogen) holes. By coupling this 
enhanced fibrinogen binding peptide with a pNIPAm microgel system capable of being 
dynamically tuned and self-assembled, we hypothesized the specific and rapidly triggered 
formation of a bulk hydrogel in a wound environment (i.e. in the presence of fibrinogen).  
Additionally for fibrin-based hemostatics, there is a need to control the final 
macroscopic properties of the matrix to enhance cell infiltration and matrix degradation 
while maintaining mechanical integrity to produce hydrogels with more regenerative 
properties for enhanced wound healing. In this study we also sought to demonstrate the 
effect of fibrin knob peptide-functionalized microgels on fibrin polymerization, structure, 
and mechanical properties using three objectives. 1) Synthesize and characterize fibrin 
knob peptide-functionalized microgels 2) Characterize fibrin polymerization, 
 xii 
degradation, composition, and structure in the presence of fibrin knob peptide-labeled 
microgels 3) Determine the mechanical properties of hybrid fibrin-microgel networks. 
We hypothesized that fibrin polymerized in the presence of fibrin knob peptide-
functionalized microgels, with specificity for fibrin(ogen) via knob:hole interactions, will 
result in altered polymerization dynamics, distinct fibrin polymer architectures, and 
altogether different physical properties of the final fibrin-microgel network.  
The results of this study showed that at the microgel and peptide conjugation 
concentrations used, the fibrinogen triggered formation of a microgel gel did not occur. 
Further optimization of knob peptide-functionalized microgels should facilitate the 
development of a fibrinogen triggered colloidal assembly of microgels for the formation 
of a hydrogel for hemostatic applications. However, we did demonstrate that fibrin 
network polymerization, structure, and viscoelastic properties were greatly altered in the 
presence of knob peptide-conjugated microgels. Further investigation of hybrid microgel-
fibrin systems in vitro will help determine the viability of these systems for different 










1.1 Background and Significance  
The need to control bleeding and wound healing presents a significant clinical 
need in surgery, trauma, and emergency medicine [1]. The loss of blood remains the 
second most prevalent cause of death in traumatic injury, with the majority of these 
deaths occurring in the pre-hospital setting [1-3]. There remains a challenge for creating 
more robust and biocompatible hemostatic agents that are available for use by EMTs and 
surgeons. There are a variety of commercial hemostatics on the market such as Quick-
Clot™, however this zeolite-based product known to cause exothermic burns upon use. 
Additionally, other hydrogel based products such as Celox™ and HemCon®, which are 
chitosan based products that work independently of the natural clotting process [4]. There 
are also thrombin and fibrin based products such as TISSEEL, Evicel®, and Crosseal™ 
which utilize the body’s natural coagulation process to form a clot, but use high 
concentrations of thrombin and fibrinogen (at least an order of magnitude greater than 
physiological concentrations) to generate a matrix with the required mechanical stability 
[5]. However, at such high protein concentrations necessary to form a substantial gel, 
there is a significant increase in polymerization rate, and the resulting gel is comprised of 
highly dense fibrin networks that are not optimal for cell infiltration [6]. For fibrin based 
hemostatics, there is a need to control the final macroscopic properties of the matrix to 
enhance cell infiltration and matrix degradation while maintaining mechanical integrity to 
produce hydrogels with more regenerative properties for enhanced wound healing.  
Fibrinogen is a 340kDa plasma glycoprotein that circulates in its inactive form in 
blood plasma at concentrations of 2-4mg/mL. In response to vascular injury, a fibrin 
polymer forms when thrombin, a serine protease, cleaves a portion of the N-termini on 
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the Aα-chain and Bβ-chain, known as fibrinopeptides A and B respectively. This exposes 
fibrin knobs ‘A’ and ‘B’ that bind to the two complementary holes ‘a’ and ‘b’ near the 
two distal C-termini of the γ- and Bβ-chains on a neighboring fibrin/fibrinogen monomer. 
These “knob: hole” interactions initiate fibrin monomer assembly in an end-to-end 
orientation to form fibrin protofibrils which make up the matrix network and are further 
stabilized by covalent crosslinking the γ- and α-chains of adjacent fibrin monomers 
within the protofibril [7-9].  
 
Figure 1. Fibrin Polymerization Scheme. [10] 
The reason this natural hemostatic system fails in major traumatic injury is due to 
massive dilution, the inability to concentrate critical clotting factors, and the failure to 
generate tissue compressive forces during polymerization. In order for a hemostatic to 
facilitate the body’s natural coagulation process, it needs to be triggered by a wound 
environment to rapidly concentrate clotting factors, speed up the formation of a clot, and 
provide compressive forces on the wound during the clotting process.  
This study aims to combine previous work utilizing fibrin binding mechanisms 
with swelling, space filling microgels for the development of a robust bio-synthetic 
hybrid polymer system with superior hemostatic and wound healing properties. Previous 
work has explored the inherent binding interactions of various fibrin knobs and their 
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complementary polymerization holes, which have led to the development of fibrin knob 
peptide mimic (GPRPFPAC) with enhanced binding affinity for fibrin(ogen) holes [11]. 
By coupling this enhanced fibrinogen binding peptide with a pNIPAm microgel system 
capable of being dynamically tuned and self-assembled, we can specifically and rapidly 
trigger the formation of a bulk hydrogel in a wound environment (i.e. in the presence of 
fibrinogen). The hypothesis is that these stimuli responsive microgels will swell and 
interpenetrate to form a colloidal assembly through their association with fibrinogen and 
provide for interesting fibrin architectures in the presence of thrombin for improved cell 
growth, differentiation, and remodeling for enhanced wound healing following the 
cessation of bleeding.  
1.2 Objectives 
The initial goal of this study was to determine the effect of fibrin knob peptide-
functionalized ultra-low crosslinked (ULC) pNIPAm microgels as a bio-synthetic 
adjuvant for hemostasis. ULC microgels have the ability to swell and extensively 
interpenetrate to maintain microgel-microgel contacts and behave as space filling 
colloidal gels at high concentrations [12, 13]. We speculated that this microgel assembly 
could be specifically triggered by fibrinogen through active fibrin knob peptide 
(GPRPFPAC)-conjugated microgels with binding affinity for fibrinogen via knob:hole 
interactions in order to rapidly form strong, swelling, and space filling gels [11]. 
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Figure 1. Schematic of Fibrinogen-Triggered Microgel Assembly 
 
In addition, we sought to demonstrate the effect of fibrin knob peptide-
functionalized microgels on fibrin polymerization, structure, and mechanical properties 
using three objectives. 1) Synthesize and characterize fibrin knob peptide-functionalized 
microgels 2) Characterize fibrin polymerization, degradation, composition, and structure 
in the presence of fibrin knob peptide-labeled microgels 3) Determine the mechanical 
properties of hybrid fibrin-microgel networks.  
1.3 Hypothesis 
We hypothesized that:  
1) Multivalent fibrin knob peptide-labeled microgels will bind specifically 
to soluble fibrinogen through stable knob:hole interactions and trigger 
the colloidal assembly of a microgel-fibrinogen network.  
2) Fibrin polymerized in the presence of fibrin knob peptide-
functionalized microgels, with specificity for fibrin(ogen) via knob:hole 
interactions, will result in altered polymerization dynamics, distinct 
fibrin polymer architectures, and altogether different physical properties 
of the final fibrin-microgel network.  
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CHAPTER 2 
LITERATURE REVIEW  
2.1 Introduction to Fibrin Hydrogels  
Fibrin networks form rapidly upon response to injury and are the body’s natural 
provisional matrix. Fibrin based products have been optimized for a variety of different 
applications such as hemostatic agents, tissue sealants, and hydrogel scaffolds for tissue 
engineering applications [14]. As a tissue sealant, the native fibrin matrix has an 
advantage by promoting and stimulating cellular infiltration as a part of the wound 
healing process, however commercially based products have dense matrices at high 
protein concentrations that inhibit cell infiltration and remodeling of the matrix for proper 
wound healing [15]. In order to enhance the properties of a fibrin matrix, growth factors 
(fibroblast growth factor, endothelial growth factor, platelet derived growth factor, etc), 
pro-fibrinolytic proteins (plasminogen, tissue plasminogen activator), antifibrinolytic 
proteins (plasminogen activator inhibitor), and other extra-cellular matrix components 
(fibronectin, heparin) have been co-purified with plasma-derived fibrinogen in 
commercial products to support the formation and remodeling of the resulting matrix [16, 
17]. Fibrin has been proven as a useful sealant in cardiac, liver, and spleen surgery, and 
fibrin hydrogels have been used widely in the recent decade in a variety of tissue 
engineering applications such as the tissue engineering of adipose, cardiovascular, ocular, 
muscle, liver, skin, cartilage, and bone tissues [14].  
 
2.2 Biosynthetic Fibrin-Polymer Hydrogels  
Fibrin hydrogels comprised of physiological levels of protein have three major 
disadvantages as a scaffold in regenerative medicine: the shrinkage of the gel during the 
formation of flat sheets, low mechanical stiffness, and rapid degradation before the 
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proper regeneration of tissue [14, 18, 19]. In order to improve these properties and 
increase the mechanical stiffness and stability of the matrix, fibrin hydrogels have been 
combined with numerous other scaffold materials including polyurethane [20], 
polyethylene oxide [21], polycaprolactone [22], heparin [23], collagen [24], hyaluronic 
acid [25], poly(L-lactic acid) and polylactic-glycolic acid [26], and polyethylene glycol 
(PEG) [27].  
Fibrin-based PEG hybrid scaffolds have been extensively studied in order to 
combine the favorable mechanical properties of PEG with the biological properties of 
fibrin. By denaturing fibrinogen and reducing disulfide bonds, then re-crosslinking the 
free sulfhydryl’s using PEG-diacrylate, Dror Seliktar’s group has utilized a multitude of 
PEG-fibrin gels with tunable structural characteristics that exhibited a range of elastic 
moduli, degradation rates, and cellular invasion kinetics [28-30]. Other groups have 
utilized fibrin based peptide-modified PEG in order to alter fibrin polymerization 
characteristics and physical properties of the formed hydrogel [5, 15, 31, 32].  
Other groups have co-polymerized fibrin with other hydrogels. Akpalo et al., have 
created interpenetrating networks of polyethylene oxide and fibrin polymerized in 
juxtaposition to greatly enhance the mechanical properties of a fibrin gel and permit cell 
growth [21]. Lesman et al, showed the combination of PLLA/PLGA sponges embedded 
with a fibrin matrix provided added mechanical strength to the construct and featured 
highly mature vessel-like networks in vitro and in vivo [26].  Dare et al., demonstrated 
that a genipin crosslinked fibrin hydrogel did not significantly affect cell viability, but 
greatly increased the dynamic compression and shear modulus of the hydrogel for 
improved mechanical properties [33]. These studies show the potential of combining the 
mechanical properties of a polymer with the biological properties of fibrin in order to 
construct scaffolds with enhanced regenerative potential.  
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2.3 Modifying Fibrin Matrices through Fibrin Knob Mimicking Peptides 
The polymerization of fibrin involves the noncovalent association of four types of 
knob:hole interactions on fibrin molecules: A:a, A:b, B:a, and B:b. The evidence for 
these knob:hole interactions was first shown when fibrin polymerization was inhibited by 
synthetic knob ‘A’ tripeptides GPR (Gly-Pro-Arg) competing for fibrin holes [34, 35]. 
Characterization of the equilibrium binding affinities of knob ‘A’ and ‘B’ variants to 
fibrinogen showed that knob ‘A’ peptide mimics GPRV and GPRP have higher affinities 
to fibrinogen than knob ‘B’ GHRP and AHRP mimics under calcium-free conditions [34-
36]. By investigating the binding events of these mimics under dynamic conditions using 
surface plasmon resonance (SPR), the residence time of noncovalent knob:hole 
interactions was determined to further understand fibrin assembly initiation and 
polymerization [11]. In this study, a novel knob ‘A’ mimic (GPRPFPAC) was presented 






) than current mimics.  
Using fibrin knob peptide technology, several methods for altering fibrin network 
structure have been employed. Knob peptide-protein constructs using GPRP, GPRV, 




 type III 
repeats (FnIII9-10) were shown to bind stably to fibrin(ogen) via specific knob:hole 
interactions and were retained within fibrin matrices under excessive perfusion [37]. 
Fibrin matrix properties were also altered using bivalent and tetravalent knob peptide-
PEG conjugates and revealed that although a significant change in network structure was 
observed, clotting time and degradation rates were not significantly altered [32]. Fibrin 
assembly was also inhibited using PEGylated fibrin knob mimics, where a 10-fold 
enhancement of anticoagulant activity was observed with active peptides PEGylated with 
5 kDa PEG [5]. Additionally in order to determine the interaction of peptides specific for 
hole ‘b’, the knob peptide (AHRPYAAC)-PEG conjugate was showed to enhance the 
porosity and diffusivity of a fibrin matrix while also increasing the viscoelastic properties 
and decreasing the susceptibility to degradation [15]. These studies have all shown 
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potential knob peptide-conjugate designs that alter fibrin polymerization and structure for 
a variety of different applications.  
 
2.4 pNIPAm Microgels in Biomedical Applications 
Synthetic hydrogels are gels that swell strongly in aqueous media and are 
typically composed of a hydrophilic organic polymer component that is cross-linked into 
a network by either covalent or noncovalent interactions [38-40]. By using specific 
chemistries and designs, hydrogels have become paramount in areas such as in vivo 
diagnostics, drug and gene delivery, chemical separations, chemical and biological 
sensors, and optical materials [41]. Stimuli-sensitive hydrogels that change in swelling 
due to subtle environmental changes are of particular interest, and one specific stimuli-
sensitive polymer with emerging potential in biotechnological applications is poly(N-
isopropylacrylamide) (pNIPAm). pNIPAm is a thermoresponsive hydrogel, characterized 
by a sharp volume phase transition at a lower critical solution temperature (LCST) where 
hydrogen bonds with the polymer chain are broken, entropically driving the formation of 
a globular polymer conformation [41]. Thus, at temperatures higher than the volume 
phase transition temperature (VPTT), the hydrogel goes from a swollen, hydrophilic state 
to a compact, relatively hydrophobic state. pNIPAm hydrogels have been synthesized by 
a variety of different techniques and various functional groups have been added to the 
polymer by copolymerization ad post-polymerization modifications [42].  
pNIPAm microgels have similar properties as their bulk counterpart, and also 
undergo a VPPT near the LCST of the polymer [43, 44]. Microgels are colloidally stable 
hydrogels whose size can vary from tens of nanometers to micrometers [45, 46] and 
posses unique characteristics for different applications due to their colloidal properties. 
pNIPAm microgels are synthesized by free-radical precipitation polymerization whereby 
a NIPAm solution containing an initiator and cross-linker is heated to above the LCST of 
the polymer (70°C) causing the free radical initiator to attack NIPAm monomers causing 
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radical propagation and chain growth. Once the chain reaches a critical length, it 
collapses on itself producing precursor particles that grow by aggregation with other 
precursor particles and upon cooling result in the formation of stable microgels.  
Usually the presence of a cross-linker is critical in preventing the dissolution of 
the polymer particle once it is cooled below the LCST, however, Gao and Frisken have 
shown that it is possible to make pNIPAm microgels by precipitation polymerization 
without using a cross-linker [47, 48]. These ultra-low crosslinked (ULC) microgels are 
“self-crosslinked” by a chain transfer reaction occurring at either or both of two possible 
sites: the hydrogen atom attached to the tertiary carbon atom on the pendant isopropyl 
group and the hydrogen atom on the tertiary carbon atom of the main-chain backbone. 
Additionally, these ULC microgels are characterized by low solid content and larger 
swelling ratios as compared to N,N-methylene bis(acrylamide) (BIS) crosslinked 
microgels [47, 48]. Another interesting property of ULC microgels is their ability to swell 
and self-associate as space filling colloidal gels in order to maximize their local 
coordination number [12, 13]. 
A variety of different pNIPAm and poly(N-isopropylmethacrylamide) 
(pNIPMAm) based microgels have been biofunctionalized for a variety of different 
applications including targeted gene delivery [49], thermally modulating enzyme activity 
[50], and DNA detection [51] amongst others. Thus pNIPAm ULC microgels present a 
viable option for bioconjugation with fibrin knob peptides, and present unique colloidal 
properties for interaction with fibrinogen and altering fibrin matrix properties.  
 
2.5 Conclusion 
By biofunctionalizing ULC microgels with fibrin knob peptides the hope is to 
dynamically trigger the colloidal assembly of microgels through knob:hole interactions in 
the presence of fibrinogen. How these peptide-functionalized microgels alter fibrin 
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polymerization, network structure, and physical properties are important factors 
determining cell fate for precise wound healing.  
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CHAPTER 3 
FIBRIN KNOB PEPTIDE FUNCTIONALIZED PNIPAM 
MICROGEL SYNTHESIS AND CHARACTERIZATION 
 
3.1 Introduction 
Previously, bivalent and tetravalent knob peptide-PEG conjugates have shown to 
alter fibrin polymerization kinetics and structure by actively engaging alternative 
polymerization mechanisms through knob:hole interactions [32]. The goal of this study 
was to utilize multivalent knob peptide-fibrinogen interactions to rapidly form a network 
even in the absence of clotting enzymes. In order to create a gel network triggered by the 
presence of fibrinogen, we rationally designed fibrin knob peptide (GPRPFPAC) 
displaying ultra-low crosslinked microgels that would associate with one another through 
fibrin knob:hole interactions and swell and interpenetrate to form a colloidal assembly.  
We developed a synthesis and conjugation strategy for active knob peptide 
(GPRPPFAC) and non-binding control peptide (GPSPFPAC)-displaying microgels. First, 
ultra-low crosslinked (ULC) pNIPAm microgels were copolymerized with 5% acrylic 
acid (AAc) using standard precipitation polymerization techniques to allow for further 
functionalization of the acid groups with fibrin knob peptides. A heterobifunctional 
linker, N-ε-maleimidocaproic acid hydrazide, trifluoroacetic acid salt (EMCH), was then 
conjugated to the carboxyl functional groups on the microgel for subsequent maleimide 
coupling to cysteine terminated fibrin knob peptides. 
Unfunctionalized ULC microgels were characterized using dynamic light 
scattering to determine hydrodynamic radius and particle polydispersity. The peptide-
microgel bioconjugation reaction was monitored using Ellman’s assay for free 
sulfhydryls to ensure complete peptide conjugation. Peptides conjugated to the microgel 
were then quantitated using a CBQCA protein quantitation assay. A modified ELISA was 
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performed to determine basic binding affinity of fibrinogen for active fibrin knob peptide 
(GPRPFPAC)-microgels.  
3.2 Methods 
3.2.1 Materials  
 All chemicals used during microgel synthesis (N-isopropylacrylamide, acrylic 
acid, and ammonium persulfate) were purchased from Sigma-Aldrich (St. Louis, MO) 
and used as received unless otherwise noted. The monomer N-isopropylacrylamide 
(NIPAm) was recrystallized from hexane (J.T. Baker) before use. Water used during the 
synthesis, purification, and characterization of microgels was distilled and then deionized 
using a Barnstead E-pure system operating at a resistance of 18MΩ. GPRPFPAC and 
GPSPFPAC peptides were ordered from GenScript Corp (Piscataway, NJ). The 
chemicals used for making conjugation and assay buffers were HEPES (EMD Chemicals, 
Cincinnati, OH), MES (EMD), sodium chloride (NaCl) (Fisher Scientific, Pittsburgh, 
PA), calcium chloride (CaCl2) (Fisher Scientific), formic acid (VWR, Radnor, PA), 
EDTA (Lonza, Allendale, NJ), BSA (EMD), Tween 20 Polysorbate 20 (VWR), DMSO 
(Amresco, Solon, OH), sodium borate (J.T. Baker), and sulfuric acid (H2SO4) (VWR).  
The coupling reagents used for peptide conjugation to microgels were N-ε-
maleimidocaproic acid hydrazide, trifluoroacetic acid salt (EMCH) (Thermo Scientific, 
Rockford, IL), 1-ethyl-3methyl-(3-dimethylaminopropyl) carbodiimide (EDC) 
(Thermoscientific), and N-hydroxysulfosuccinmide (NHSS) (Thermoscientific). For 
Ellman’s assay the chemicals needed were Ellman’s reagent 5,5'-Dithio-bis-(2-
nitrobenzoic acid) (DTNB) (Thermoscientific) and L-(+)-Cysteine Hydrochloride 
Monohydrate (J.T. Baker). The CBQCA protein quantitation kit was purchased from 
Invitrogen (Frederick, Maryland) for peptide quantitation. The reagents used in the 
ELISA binding assay were polyethyleneimine (PEI) (J.T. Baker), N-Hydroxysuccinimide 
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(NHS) (Thermoscientific), human fibrinogen (FIB-3, Enzyme Research Laboratories, 
South Bend, IN), HRP-conjugated goat anti-fibrinogen antibody (MP Biomedicals 
#55239), and 1-step Ultra TMB substrate (Pierce #34028). 
3.2.2 Ultra-Low Crosslinked (ULC) pNIPAm Microgel Synthesis 
 Ultra-low crosslinked pNIPAm microgel particles were synthesized by free-
radical precipitation polymerization. The molar composition used was 95% N-
isopropylacrylamide (NIPAm) and 5% acrylic acid (AAc), with a total monomer 
concentration of 140 mM. Copolymerization with AAc was done to allow for 
chemoligation sites for peptide attachment. Reaction conditions were used that favor 
chain transfer reactions at the polymer backbone which lead to cross-linking between 
chains without the need for additional cross-linking monomers [47, 48]. In a typical 
reaction, 100 mL of a filtered aqueous solution of recrystallized NIPAm and AAc was 
added to a reaction flask and heated to 70°C at a temperature ramp of 60°C/hr. The 
solution was purged with N2 gas and stirred at 450 rpm while heating until the 
temperature remained stable. In order to initiate the polymerization reaction, a filtered 1 
mL solution of ammonium persulfate (APS) was added to make the final concentration of 
APS in the reaction ~1 mM. The solution turned turbid, indicating successful initiation. 
The reaction was allowed to continue at 70°C for 5 hours under a N2 blanket and 
continuous stirring before allowing the solution to cool to room temperature. Following 
synthesis, the solution was filtered through glass wool to remove a small amount of 
coagulation, and purified 5X by centrifugation at 100,000 rpm for 15 minutes and 
resuspension in dH2O. The microgels were lyophilized until further use.  
3.2.3 Dynamic Light Scattering (DLS) Particle Analysis  
Monodispersity and hydrodynamic radius of the microgels were determined using 
dynamic light scattering (DLS) at 25°C in pH 3 0.1 M formate buffer. A dilute microgel 
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solution in formate buffer was allowed to equilibrate for 10 minutes prior to taking 5 
measurements of 20 readings each to obtain an average value for the hydrodynamic 
radius and polydispersity.  
3.2.4 Fibrin Knob Peptide Conjugation to Microgels  
Fibrin knob peptides with sulfhydryl-containing cysteine-terminated ends 
(GPRPFPAC and the non-binding control peptide GPSPFPAC) were the two peptides 
used for conjugation to microgels. Peptide conjugation to pNIPAm microgels was done 
using a two-step conjugation method. Firstly, a maleimide-functionalized microgel was 
produced through EDC/NHSS coupling of a heterobifunctional crosslinker, N-ε-
maleimidocaproic acid hydrazide, trifluoroacetic acid salt (EMCH) to the carboxyl 
groups on the microgel. Then the fibrin knob peptides were conjugated to the EMCH 
groups on the microgels via maleimide coupling to the free cysteine residues on the C-
termini of the peptides. Peptide coupling was done by introducing the peptides at a 1:1 
molar ratio with the carboxyl groups. Coupling reagents were used in 10 mol excess of 
peptide to ensure complete coupling and all bioconjugation reactions were carried out in 
a 10 mL reaction volume.  
For the first step of the coupling process, the calculated amount of microgels was 
resuspended at room temperature in pH 5.0 MES buffer overnight. 1-ethyl-3methyl-(3-
dimethylaminopropyl) carbodiimide (EDC) and N-hydroxysulfosuccinmide (NHSS) were 
reacted with the microgel solution for 30 minutes on a shaker to activate the carboxyl 
groups. The EMCH was then added to the microgel solution and reacted for 2.5 hours to 
permit coupling between the carboxyl reactive hydrazide groups on the EMCH and the 
carboxyl groups on the microgel surface. In order to remove any unreacted material and 
to exchange to a pH 7.4 25 mM HEPES, 25 mM NaCl buffer for the maleimide coupling, 
a 10 kDa snake skin dialysis membrane (Thermoscientific, Rockford, IL) was used and 
the buffer replaced 5 times every 4 hours. For the second step of the conjugation reaction, 
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the appropriate amount of peptide was added to the maleimide activated microgels and 
reacted overnight on a shaker. Excess unconjugated peptide was removed from the 
peptide-functionalized microgels using the 10 kDa snake skin membrane and dialyzed 
into dH2O with the solution being replaced 5 times every 4 hours. The resulting product 
was aliquoted, lyophilized and quantified.  
3.2.5 Ellman’s Assay for Free Sulfydryls  
The bioconjugation reaction was monitored using Ellman’s assay for free 
sulfhydryls. 5,5’-dithio-bis-(2-nitrobenzoic acid), also known as DTNB or Ellman’s 
Reagent, is a water-soluble compound used for quantitating free sulfhydryl groups in 
solution [52]. DTNB reacts readily with a free sulfhydryl group to yield a mixed disulfide 
and 2-nitro-5-thiobenzoic acid [52], which produces a yellow-colored product which can 
be measured using a standard plate reader. This reagent can be used to detect the free 
sulfhydryl groups on C-terminal cysteines and determine the concentration in solution by 
comparison to a standard curve of known concentrations of a sulfydryl-containing 
compound.  
Ellman’s assay was used to determine if there were any unreacted peptides in the 
bioconjugation reaction of the fibrin knob peptides with the maleimide functionalized 
microgels. The detectable range of the assay is 0.1 – 1.0 mM, and the standard curve was 
generated using cysteine standards. Free peptide, unconjugated microgels, and 
(unconjugated microgels + free peptide) were used as controls. The conjugation reaction 
was monitored for 1hour to detect for the presence of unconjugated peptide.  
In order to prepare the Ellman’s reagent, 4.5 mg of DTNB was dissolved into 3 
mL of a pH 7.4 25 mM HEPES, 25 mM NaCl, 1 mM EDTA reaction buffer. 5 uL of this 
Ellman’s solution and 85 uL of the reaction buffer were added to each well of a 96 well 
plate. 10 uL of each sample was added to separate wells at time points of 0, 15, 30, 45, 
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and 60 mins, and the absorbance of the solution was measured at 412 nm using a 
SpectraMax M2 Microplate Reader (Molecular Devices, Sunnyvale, CA).  
3.2.6 Peptide Quantitation Assay 
Amines on the peptide-labeled microgels were quantified using the CBQCA 
Protein Quanititation Kit with the respective peptides used to generate the standard curve. 
The CBQCA protein quantitation assay is a quick and highly sensitive method for the 
quantitation of proteins in solution ranging from 10 ng-150 ug of protein [53]. The 
ATTO-TAG™ CBQCA reagent is used to quantitate primary amines in solution, 
including the accessible amines in proteins and peptides, by forming highly fluorescent 
derivatives in the presence of cyanide that can be measured using a standard plate reader. 
[53].  
Peptide standards and peptide-microgel samples were prepared in pH 9.3 0.1 M 
sodium borate buffer for a final volume of 135 uL added to separate wells of a 96 well 
plate. 5 uL of a 20 mM potassium cyanide (KCN) solution was added to each well. A 5 
mM working solution was prepared from a 40 mM CBQCA stock solution, and 10 uL of 
this working solution was added to each well, mixed on an Eppendorf MixMate at 400 
rpm and allowed to incubate for 1 hr in the dark before measuring the fluorescence at Ex. 
465 nm/Em. 550 nm using a BioTek Synergy H4 Hybrid Multi-Mode Microplate Reader 
(BioTek, Winooski, VT). 
3.2.7 Fibrinogen-Microgel Binding Affinity Assays 
A modified ELISA technique was used to determine the affinity of fibrinogen for 
the various fibrin knob peptide-labeled microgels covalently immobilized to the bottom 
of 96 well plates via their carboxyl containing groups using EDC/NHS chemistry. 5 
mg/mL polyethyleneimine (PEI) was used to coat Corning® clear bottom 96 well plates 
(Sigma Aldrich) for at least 2 hours in order to create a positively charged hydrophilic 
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surface. After washing the plates, 1 mg/mL microgel solutions in dH2O were 
centrifugally deposited for 10 min at 3700 rpm, then conjugated directly to the PEI layer 
via additional unreacted carboxyl groups on the peptide-labeled microgels using 
EDC/NHS. Unreacted microgels were removed by washing with dH2O, and were blocked 
with HEPES + Ca + 1% BSA buffer (25 mM HEPES, 150 mM NaCl, 5 mMCaCl2, pH 
7.4) for 1 hour prior to the fibrinogen binding step. 
 Human fibrinogen at 25 ug/mL was incubated with the microgel substrates and 
unbound protein removed by washing. Bound fibrinogen was detected using HRP-
conjugated goat anti-fibrinogen antibody and 1-step Ultra TMB substrate. The detection 
antibody was added at a concentration of 1:50,000 in 1% BSA to each well and incubated 
for 1hr before washing off any unbound antibody. TMB substrate was added to each well 
and allowed to incubate for 8min at room temperature. The TMB reaction was quenched 
with 1 M H2SO4 before measuring the Absorbance at 450 nm using a BioTek Synergy H4 
Hybrid Multi-Mode Microplate Reader (BioTek, Winooski, VT). All intervening wash 
steps were conducted using HEPES + Ca + 0.05%Tween-20 buffer; and all binding steps 
were conducted using HEPES +Ca +1% BSA buffer. A standard curve was generated 
using dilutions of fibrinogen bound directly to the plate, and each condition was tested 
with at least 9 samples.  
3.3 Results 
3.3.1 Hydrodynamic Radius of Microgels 
The hydrodynamic radius <Rh> of 5% AAc-pNIPAm microgels at 25°C in pH 3 
0.1 M formate buffer as measured by DLS was 474.1 nm, with a polydispersity index of 





3.3.2 Monitoring the Peptide Conjugation Reaction 
The microgel concentration in the GPRPFPAC-microgel bioconjugation reaction 
was estimated to be 1.28 mg/mL, and the peptide concentration in the reaction was 
estimated to be 0.567 mM. To reflect similar concentrations, the unconjugated microgel 
control was measured at 1.28 mg/mL, and the GPRPFPAC free peptide control was 
measured at 0.5 mM. The microgel concentration in the GPSPFPAC-microgel 
bioconjugation reaction was estimated to be 1.715 mg/mL, and the peptide concentration 
in the reaction was estimated to be 0.757 mM. To reflect similar concentrations, the 
unconjugated microgel control was measured at 1.715 mg/mL, and the GPSPFPAC free 
peptide control was measured at 0.75 mM. Based on the cysteine standard curve, the 
controls fall within the correct concentration range (Fig. 3). The results of the assay 
demonstrate that the peptides react with the maleimide functionalized microgels almost 
instantaneously after being added to solution, but do not react with unconjugated 
microgels, indicating that the bioconjugation reaction is a specific and rapid reaction 
carried out to completion in approximately one hour. The peptide-microgel conjugation 
reaction was allowed to carry out for at least 2.5 hours to ensure complete conjugation.  
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Figure 3. Ellman’s Assay for Monitoring Peptide Conjugation to Microgels. (A) 
GPRPFPAC-microgel bioconjugation reaction, showing reaction specificity of peptides 
for EMCH conjugated microgels (B) GPSPFPAC-microgel bioconjugation reaction, 
showing similar reaction time and specificity for EMCH conjugated microgels.  
3.3.3 Peptide Quantification 
The CBQCA protein quantitation assay was used to quantify amines on fibrin 
knob peptide labeled microgels in order to determine the amount of peptide conjugated 
per milligram of microgels. A standard curve was generated using triplicate samples of 
peptide solutions ranging from 0 mM to 0.75 mM. Linear regression analysis was 
performed for each peptide standard, which resulted in a line of best-fit for GPRPFPAC; 
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y=36730x + 3959 with an r
2
 value of 0.938, and GPSPFPAC; y=25800x + 2128 with an 
r
2
 value of 0.9604. An estimate of the amount of peptide per milligram of microgels was 
determined from these peptide standard curves. The amount of GPRPFPAC peptide per 
miligram of microgels is 1.45e-8 mols , which corresponds to a peptide concentration of 
0.0145 mM per mg/mL of microgels. The amount of GPSPFPAC peptide conjugated to a 
miligram of microgels is 8.1e-8 mols, which corresponds to a peptide concentration of 
0.081 mM per mg/mL of microgels. 
 
Figure 4. CBQCA Peptide Quantitation Assay of Peptide Functionalized Microgels. 
(A) Standard curve of respective fibrin knob peptides (B) peptide quantitation of peptide-
microgels showing microgel concentration dependent signal.  
3.3.4 Fibrinogen Binding Affinity for Peptide Modified Microgels 
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In order to determine the basic binding affinity of fibrinogen for GPRPFPAC-
microgels, a modified ELISA technique was used to detect fibrinogen bound to microgel 
coated plates by using an anti-fibrinogen HRP-conjugate. The amount of soluble 
fibrinogen absorbed to the microgels was normalized against the signals obtained from 
dilutions of fibrinogen bound directly to the plate. The ELISA results indicate that 
soluble fibrinogen preferentially bound to GPRPFAC-microgel coated wells, but not the 
unfunctionalized microgels or the non-binding GPSPFPAC-microgel controls. An 
unpaired t-test with a 95% confidence level and corresponding p value <0.05 was 
considered significant (Prism 5, GraphPad Software, Inc., La Jolla, CA).  
 
Figure 5. ELISA studies analyzing fibrinogen affinity for GPRPFPAC-microgels. 
Fibrinogen affinity for GPRPFPAC-microgels as compared to unfunctionalized microgels 
and non-binding GPSPFPAC-microgel control. The amount of soluble fibrinogen 
absorbed to the microgels was normalized against the signals obtained from dilutions of 





The CBQCA peptide quantitation assay is a simple estimate for the amount of 
peptide conjugated to the microgels. The results showed that even though sufficient 
numbers of peptide were conjugated to the microgels, based on the amount of peptides 
conjugated per mg of microgel and the amount of microgels used for conjugation, the 
calculated percent yield for peptide conjugation to the microgels was extremely low. The 
percent yield for GPRPFPAC peptide conjugation to the microgels was only 3.3% and 
slightly higher for GPSPFPAC peptide conjugation at 18.3%. Although the ELISA 
results show preferential binding of fibrinogen to the active knob peptide (GPRPFPAC)-
microgels, the amount of fibrinogen bound to the microgels is only slightly over 20% of 
25 ug/mL fibrinogen bound directly to the bottom of an unblocked plate. These results 
show that while the formation of multivalent peptide-displaying microgels with 
specificity for fibrinogen is possible, better control of the conjugation reaction, more 
efficient binding of peptides to the microgels, and better control of ligand density is 
required for homogeneous multivalent display of peptides on the microgel.  
Although the Ellman’s assay results suggest complete conjugation of the peptides 
to the microgels, it is possible that the loss in signal is due to peptide dimer formation that 
occurs through disulfide bonds via the free C-termini cysteines on the peptides. In order 
to prevent the formation of dimers, the reaction pH and reducing/oxidizing conditions 
need to be monitored closely and the conjugation reaction possibly altered completely to 
facilitate more efficient peptide conjugation. 
Peptide ligand density and homogenous or heterogeneous display of peptides on 
the microgels is a critical factor influencing peptide-fibrinogen association to form a 
colloidal assembly and a key parameter influencing fibrin polymerization. Multi-angle 
laser light scattering of ULC microgels can be used to determine the molecular weight of 
the microgels and allow for the estimate of the number of peptides conjugated per 
microgel. While this was not performed with the microgels in this study, because the 
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percent yield of peptides conjugated to the microgels is so low, it suggests the formation 
of heterogeneous peptide display on the microgels. Better control of ligand density on the 
microgels is necessary for further study of fibrin knob peptide-microgel interactions with 
fibrin(ogen). Studying the influence of ligand density on microgel assembly formation 
and fibrin polymerization is crucial for determining optimal peptide multivalency for 
triggering a colloidal assembly of microgels and significantly altering fibrin 
polymerization. The rational design of the next generation of peptide-microgel conjugates 
will be described in the discussion of the next chapter. 
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CHAPTER 4 
HYBRID MICROGEL-FIBRIN CLOTS: ALTERING FIBRIN 
POLYMERIZATION, COMPOSITION, AND STRUCTURE 
 
4.1 Introduction 
By synthesizing multivalent fibrin knob peptide-conjugated microgels, we hoped 
to trigger the colloidal assembly of microgels through knob:hole interactions in the 
presence of fibrinogen. We measured fibrinogen-microgel assembly by observing the 
change in turbidity upon the addition of fibrinogen to a solution of peptide-conjugated 
microgels and physically determined whether a gel was formed. However, the peptide- 
microgel concentration was not optimal for forming a colloidal assembly in the presence 
of fibrinogen alone.  
 Despite this, we predicted that in the presence of low concentrations of thrombin, 
knob peptide-conjugated microgels would act as an adjuvant for fiber network formation 
and increase the overall rate of polymerization into a gel network by providing nucleation 
sites through multivalent peptide display for association with fibrin monomers for the 
formation of a microgel-fiber network.  
The dynamics of fibrin assembly into a network and alterations to assembly 
kinetics have been extensively studied [54]. Fibrin network polymerization kinetics and 
structure can be modified by varying ionic strength (NaCl concentration), calcium 
concentration, fibrinogen and thrombin concentration, pH, and the use of alternative 
thrombin-like clotting enzymes [55-57]. Knob:hole interactions initiated by the removal 
of fibrinopeptides are crucial in determining important network parameters such as fiber 
diameter and branching, both of which can be detected from clot turbidity measurements 
[58]. Translucent clots are formed with high thrombin concentrations or high NaCl 
concentrations, and are commonly interpreted to be thin, highly-branched networks. 
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Opaque clots are formed at low NaCl or high calcium concentrations, which are 
conditions that have been shown to favor lateral aggregation of the fibrin protofibrils, 
giving rise to thicker bundles that scatter more light.  
The addition of synthetic fibrin knob peptide mimics alters fibrin matrix 
formation and perturbs clot turbidity depending on the type of knob mimic [35]. At high 
concentrations over 100-fold molar excess, fibrin knob ‘A’ peptide derivatives such as 
GPRP-mimics inhibit fibrin polymerization and increase fibrinogen clotting time by 
competing with native fibrin knobs for polymerization hole domains [34]. However, at a 
1:1 molar ratio, fibrin polymerization is not inhibited but rather fibrinogen molecules are 
pre-engaged through knob:hole interactions with the peptides prior to fibrin 
polymerization [15].  
In addition to the alteration of fibrin polymerization and structure through the 
addition of fibrin knob peptide mimics, bivalent and tetravalent knob-PEG conjugates 
with size ranges from 2 to 20 kDa have shown to alter the clotting characteristics of fibrin 
in a dose-dependent manner, with conjugate size playing a major role in changing fibrin 
network structure [32]. PEGylated fibrin knob ‘A’ peptides demonstrated a biphasic 
effect of PEG chain length, with increasingly enhanced inhibition of fibrin 
polymerization from 0 to 5 kDa, but above 5 kDa returning to control levels [5]. Other 
polymers, either natural or synthetic, have been copolymerized with fibrin, embedded 
within fibrin matrices, or cross-linked with fibrin in order to combine the properties of 
the two polymers for enhanced mechanical strength, greater resistance to degradation, 
increased protein retention, and unique architectures for various tissue regeneration 
applications.  
In vivo, the events that trigger coagulation also initiate the process of fibrinolysis 
 through the activation of plasminogen to generate the active serine protease, plasmin. 
The fibrinolytic process is modulated by a complex of several biochemical processes 
involving plasminogen activators, plasminogen activator inhibitors, and fibrinolysis 
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inhibitors. Exogeneous fibrinolysis, which is independent of plasmin activation, involves 
overlaying a solution of active plasmin on top of a stable clot and measuring the surface 
degradation [59]. Exogeneous fibrinolysis is a diffusion dependent phenomenon and the 
lysis rate has been shown to decrease with fibrin fiber diameter [59-61]. Another study 
showed that thinner fibers are digested more quickly, but thicker fibers are more likely to 
undergo agglomeration, which has been shown to accelerate fibrinolysis [62]. The 
introduction of fibrin knob peptide-PEG conjugates to a fibrin polymer resulted in more 
porous networks with nearly doubled effective diffusion coefficients over control groups, 
however, because the degradation profiles were similar, it was speculated that lysis is 
mediated both by diffusion limits and conformational alterations in the fibrin fibers [15]. 
Diffusion into fibrin knob peptide-PEG conjugate fibrin gels occurred at a faster rate due 
to the coarsely porous network, but plasmin binding and lysis occurred at a slower rate 
due to the structural alteration of fibrin fibers [15].  
We hypothesize that fibrin polymerized in the presence of fibrin knob peptide-
functionalized microgels will alter polymerization kinetics, degradation rate, protein 
composition and fibrin network structure. Microgel size and concentration, peptide ligand 
density, and thrombin concentration are expected add to the complexity of this fibrin-
microgel system. We studied the polymerization kinetics of fibrin polymerized in the 
presence of various peptide-microgel conjugates through clot turbidity measurements, 
analyzed the soluble protein in the final clot using a Quant-iT™ Protein Assay, analyzed 
the degradation rate by an exogenous fibrinolysis assay, and observed the structure of the 








Synthesized unfunctionalized pNIPAm microgels, GPRPFPAC-microgels, and 
GPSPFPAC-microgels, all described in Chapter 3, were used for these studies. Human 
fibrinogen FIB-3 and human α-thrombin were purchased from Enzyme Research 
Laboratories (South Bend, IN). For the buffers HEPES (EMD), NaCl (Fisher Scientific), 
CaCl2 (Fisher Scientific), and deionized and distilled water were used. Alexa Fluor 555® 
succinimidyl ester Protein Labeling Kit (Invitrogen, Frederick, Maryland) was used to 
fluorescently label fibrinogen for confocal microscopy of fibrin-microgel clots. Quant-
iT™ Protein Assay Kit (Invitrogen, Frederick, Maryland) was used to analyze the amount 
of protein incorporated into the clot.  
4.2.2 Fibrin Polymerization in the Presence of Microgels 
Thrombin catalyzed polymerization of mixtures of fibrinogen and various fibrin 
knob peptide-labeled microgels (unfunctionalized microgels, GPRPFPAC-microgels, and 
GPSPFPAC-microgels) was initiated in transparent 96-well plates. In this assay, 
thrombin concentration dependent polymerization was observed for fixed concentrations 
of fibrinogen (1 mg/mL) and microgels (1 mg/mL, 2.5 mg/mL) with a fibrinogen-
microgel to thrombin volume ratio of 9:1. The rationale for choosing 1 mg/mL and 2.5 
mg/mL of microgels was in order to create a balanced effect of fibrin and microgels 
within the network. At lower microgel concentrations the network is dominated by fibrin 
and the effect of microgels is no longer significant. At higher microgel concentrations, 
the effect of microgels outweighs fibrin and the ability to form a fibrin network is 
hindered. Fibrinogen and microgel solutions were mixed and incubated together in 
HEPES + Ca buffer for 2 hours at room temperature and turbidity readings taken prior to 
adding various concentrations of human α-thrombin for a final thrombin concentration of 
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0, 0.01, 0.025, 0.05, 0.075, 0.1, 0.25, and 0.5 National Institute of Heath standard (NIH) 
units/mL. The clot turbidity at an absorbance of 350 nm was measured for 2 hours using 
a SpectraMax M2 Microplate Reader (Molecular Devices, Sunnyvale, CA) with readings 
taken every minute. From the turbidity curves, it was possible to determine the final 
turbidity of the mixture (normalized against controls without thrombin by subtracting 
initial turbidity without thrombin), and the clotting half time- the time taken for the clot 
to reach half the final normalized turbidity value at 2 hrs following thrombin addition. 
Each condition was tested with at least six samples.  
4.2.3 Protein Incorporation into Fibrin-Microgel Clots 
Following the turbidity assay, to determine the amount of unclotted protein, the 
clot was removed, and the isolated clot liquor was analyzed for total soluble protein using 
the Quant-iT™ Protein Assay. The Quant-iT™ protein reagent is highly selective for 
protein, with little protein-protein variability in the range of 0.25-5 ug. A working 
solution was prepared by diluting the Quant-iT™ protein reagent 1:200 in the provided 
buffer, and 200 uL of the solution added into each well of a black 96 well plate. 5 uL of 
each provided BSA standard was added to separate wells with duplicates of each 
concentration to create a standard curve by measuring the fluorescence at (Ex. 479/Em. 
570 nm) using the BioTek Synergy H4 Hybrid Multi-Mode Microplate Reader (BioTek, 
Winooski, VT). 5 uL of the clot liquor from each sample was added to separate wells 
with duplicates of each in order to determine the amount of soluble protein in the clot 
liquor. The percent clottable protein was then back calculated from the amount of soluble 
protein in the clot liquor and normalized against controls without thrombin. Each 





4.2.4 Exogenous Fibrinolysis of Fibrin-Microgel Clots 
Fibrin-microgel clot degradation was evaluated using an exogenous fibrinolysis 
assay. Fibrin-microgel clots were prepared as in section 4.2.2 using a final thrombin 
concentration of 0.25 U/mL to allow the clots to reach their final turbidity at 2 hours. 100 
uL of plasmin (0.5 U/mL) was overlaid on top of the fibrin-microgel clots and gently 
agitated at room temperature for 4 hours on an Eppendorf MixMate at 400 rpm. Every 
thirty minutes, turbidity readings were recorded at 350 nm using a SpectraMax M2 
Microplate Reader (Molecular Devices, Sunnyvale, CA) and 5 uL samples from the clot 
liquor were taken to determine total soluble protein using the Quant-iT protein assay (see 
Section 4.2.3 for experimental details). The turbidity readings were normalized by 
subtracting the initial turbidity of the solution prior to thrombin addition. The percent 
soluble protein in the clot was calculated based on the theoretical maximum 
concentration of protein.  
4.2.5 Confocal Imaging of Fibrin-Microgel Clot Structure  
Fluorescently-labeled FIB-3 fibrinogen was prepared by conjugation to the amine 
reactive Alexa Fluor 555® succinimidyl ester following the manufacturer’s 
recommended protocol. Clots containing 10% labeled fibrinogen were imaged using the 
Zeiss 510 laser scanning confocal microscope (Carl Zeiss, Thornwood, NY). Mixtures of 
10 uL fibrinogen and 10uL microgels were preincubated in HEPES + Ca buffer for 1 
hour prior to 20 uL thrombin addition, for a final concentration of 1 mg/mL fibrinogen, 
0.25 U/mL thrombin, and 1 mg/mL, 2.5 mg/mL, and 5 mg/mL unfunctionalized, 
GPRPFPAC conjugated, or GPSPFPAC conjugated microgels. Following the addition of 
thrombin, the solutions were quickly mixed by pipetting and immediately added to a 
glass slide. The mixture was covered with a glass coverslip supported by 0.3 mm spacers 
on two sides. The open sides were sealed with nail polish to create a chamber, and the 
mixture was allowed to polymerize for 1hour before imaging. A 10 um Z-stack of 20 
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(0.53 um) slices under the 63X objective was captured for reconstructing the 3D fibrin 
network structure. At least 3 clots were formed independently for each condition, and 4 
random sections were imaged per clot.  
In order to visualize the interaction of the microgels in the fibrin network 
structure, 0.1 M 4-acrylamidofluorescein (AFA) labeled microgels were synthesized 
using the same method as for unlabeled microgel synthesis and were conjugated with 
peptides and incorporated into clots for confocal imaging shown in APPENDIX A. 
4.3 Results 
In this study, the ability of fibrinogen to trigger active knob peptide GPRPFPAC-
microgel assembly was determined. In addition, the effect of microgels conjugated to 
active knob peptide (GPRPFPAC) or inactive control peptide (GPSPFPAC) and 
unfunctionalized microgels on fibrin polymerization was investigated. Clot turbidity and 
percent clottable protein measurements were performed using various concentrations of 
thrombin, with the readings normalized against controls without thrombin. All 
experimental groups were tested with at least two triplicate trials. There was a large 
variance in the results with fibrin polymerized in the presence of various fibrin knob 
peptide-microgels at different thrombin concentrations for significant statistical 
comparison. However general trends in the data are described in the sections below.  
4.3.1. Fibrinogen-Triggered Microgel Assembly  
Figures 6A and 7A of 1 mg/mL and 2.5 mg/mL microgel + fibrinogen solutions 
without the presence of thrombin show no change in turbidity due to microgel:fibrinogen 
interactions. A clear mixture is indicative of the absence of fibril assembly and clot 
formation. Additionally, these microgel + fibrinogen solutions resulted in no observable 
physical formation of a clot, but remained an aqueous solution even after a 2+ hour 
incubation of the microgels with fibrinogen. Interesting, the active knob peptide 
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GPRPFPAC-microgel containing clots do not increase the absorbance of the mixture as 
previously shown in another study [32], suggesting that the peptide-microgel conjugate 
concentration in solution is not enough to result in fibrinogen-microgel assembly arising 
from knob:hole interactions despite the multivalency of the microgels.  
4.3.2 Fibrin-Microgel Clot Turbidity 
4.3.2.1 Clot Turbidity Profiles 
Turbidity curves for clots polymerized in the presence of 1 mg/mL microgels at 
various thrombin concentrations are presented in Figure 6. In Fig. 6B, for the 0.01 U/mL 
thrombin condition, delayed polymerization occurs for all microgel containing clots. This 
decrease in the polymerization rate indicates a competition effect of microgels altering 
the equilibrium rates of thrombin cleavage and fibrin monomer association at the low 
concentrations of thrombin. However, at thrombin concentrations of 0.025 U/mL and 
higher (Fig. 6C-H), the clots polymerized with microgels experience similar 
polymerization rates as the fibrin alone control, which indicates that at higher thrombin 
concentrations, the competitive effect of microgels is overcome to form a fiber network at 
similar rates. The effect of molecular crowding due to the microgels and the alteration in 
polymerization rate is explained further in the discussion section. In addition to a trend in 
polymerization rates, all clots polymerized in the presence of microgels observe a higher 
final turbidity. In general, an increase in clot turbidity indicates the formation of thicker 
fibrin bundles, whereas thinner fibrin bundles result in clear or glassy clots. This increase 
in clot turbidity suggests that thicker fiber bundles are formed in the presence of 
microgels.  
Turbidity curves for clots polymerized in the presence of 2.5 mg/mL microgels at 
various thrombin concentrations are presented in Figure 7. In Fig. 7B- E, clots 
polymerized with 0.01-0.075 U/mL thrombin have delayed polymerization rates for all 
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microgel containing samples. This decrease in the polymerization rate for higher 
thrombin concentrations as compared to the 1mg/mL microgel conditions, can be 
attributed to the increased effect of competition by the microgels at higher 
concentrations. However, from 0.1-0.5 U/mL (Fig. 7F-H) the microgel containing clots 
experience similar polymerization as the control, suggesting that the rate of fibrin 
monomer formation to associate and form fibrils has overcome the competitive effect of 
the microgels. In addition, these clots result in higher final turbidity for all microgel 
conditions suggesting that while the polymerization rate is delayed, thicker fiber bundles 
are being formed.  
Surprisingly, instead of observing increased rates of polymerization for the 
GPRPFPAC microgel condition, highly delayed polymerization rates are observed for 
low thrombin concentrations. In Fig 7B and 7C, at the 0.01 and 0.025 U/mL thrombin 
conditions, GPRFPAC microgels do not reach their final turbidity and display highly 
inhibited polymerization rates. This result reveals that the GPRPFPAC-microgels do not 
serve as nucleation sites for polymerization, but rather act as competitors with native 
fibrin monomers for polymerization into fibers. This result is corroborated by studies 
showing inhibition of fibrin polymerization by GPRP peptides and GPRP-PEG 
conjugates [5, 32]. However, at concentrations of 0.05 U/mL of thrombin and above (Fig. 
7D-H) GPRPFPAC-microgels start to approach their final turbidity at 2 hours suggesting 
that at higher thrombin concentrations enough fibrin monomers are generated to 
overcome both competition due to microgels as well as competition of the peptide 
conjugated microgels for fibril formation.  
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Figure 6. Turbidity Profiles of Fibrin Polymerized in the Presence of 1 mg/mL 
Microgels. 1 mg/mL fibrinogen polymerized for 2 hours in the presence 1 mg/mL of 
peptide labeled microgels (unfunctionalized microgels, GPRPFPAC-microgels, 
GPSPFPAC-microgels) at different thrombin concentrations - (A) No thrombin (B) 0.01 
U/mL (C) 0.025 U/mL (D) 0.05 U/mL (E) 0.075 U/mL (F) 0.1 U/mL (G) 0.25 U/mL (H) 
0.5 U/mL.  
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Figure 7. Turbidity Profiles of Fibrin Polymerized in the Presence of 2.5 mg/mL 
Microgels. 1 mg/mL fibrinogen polymerized for 2 hours in the presence 2.5 mg/mL of 
peptide labeled microgels (unfunctionalized microgels, GPRPFPAC-microgels, 
GPSPFPAC-microgels) at different thrombin concentrations - (A) no thrombin (B) 0.01 
U/mL (C) 0.025 U/mL (D) 0.05 U/mL (E) 0.075 U/mL (F) 0.1 U/mL (G) 0.25 U/mL (H) 
0.5 U/mL.  
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4.3.2.2 Final Clot Turbidity 
The addition of microgels to the fibrin network seems to generally increase the 
final clot turbidity for thrombin conditions that result in similar polymerization rates as 
the fibrin control. This increase in final turbidity suggests the formation of thicker fiber 
bundles, possibly due to macromolecular crowding by the microgels. The effect of 
macromolecular crowding on fibrin polymerization is explored in more detail in the 
discussion.  In Fig. 8A, clots polymerized with 1mg/mL microgels with different 
thrombin concentrations all reach final clot turbidity at the end of 2 hours. However in 
the 2.5 mg/mL microgel condition, GPRPFPAC-microgels do not reach final clot 
turbidity at 0.01 and 0.025 U/mL (Fig. 8B). It only approaches final clot turbidity at 0.05 
U/mL and above. Interestingly, the overall trend shows that clots polymerized with 
GPSPFAC-microgels have the highest overall clot turbidity, which indicates the 
formation of thicker fiber bundles. In addition, final clot turbidity does not change much 
for unfunctionalized microgels at different thrombin concentration and appears to be 
lower than other microgels for all conditions, which indicates the formation of thinner 
fibers than all the other microgel conditions. While the reason for the difference in final 
turbidity between different peptide-microgel conjugates is uncertain, it is possible that 
microgel charge plays an important role in fibrin polymerization by altering fibril 
formation, structure, and organization. The effect of microgel charge on fibrin 




Figure 8. Final Turbidity of Fibrin-Microgel Clots. Final turbidity values of fibrin-
microgel clots after polymerizing for 2 hours, normalized against controls without 
thrombin. (A) clots polymerized with 1 mg/mL microgels (B) clots polymerized with 2.5 
mg/mL microgels.  
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4.3.2.3 Clotting Half-Time 
The clotting half time as defined by the time needed to reach ½ the normalized 
final turbidity value at 2 hours, was only calculated for clots reaching final turbidity after 
2 hours of polymerization shown by * in Figure 9. The clotting half-time for clots 
polymerized with 1 mg/mL microgels is shown in Fig. 9A. There is a thrombin 
concentration dependent response where the clotting half-time is greater for clots 
containing microgels polymerized with low concentrations of thrombin (less than 0.1 
U/mL).  This impedance of rapid fiber formation is likely due to the competetive effect of 
microgels altering equilibrium rates of fibrin monomer formation and association for 
network formation. At 0.1-0.5 U/mL thrombin, the clotting half-time for all microgel 
containing clots approaches the same time as the control suggesting that at high thrombin 
conentrations, sufficient fibrin monomers are generated to overcome the competitive 
effect of microgels. The clotting half-time for clots polymerized with 2.5 mg/mL 
microgels is shown in Fig. 9B. The same trend is observed for GPFPFAC-microgels and 
GPRPFPAC-microgels at this concentration as the 1 mg/mL condition that at low 
thrombin concentrations there is an increased delay in polymerization rate from 0.01-
0.075 U/mL thrombin and even slightly at 0.1 and 0.25 U/mL thrombin. GPRPFPAC-
microgels greatly increased the clotting half-time up to 0.075 U/mL and did not reach 
final turbidity for the 0.01 and 0.025 U/mL thrombin conditions. Interestingly, the 2.5 
mg/mL unfunctionalized microgel condition did not vary greatly from the fibrin alone 
control for all thrombin concentrations. This difference from the non-binding 
GPSPFPAC-microgel control could be due to differences in microgel charge, explained 
in the discussion section. GPSPFPAC- microgels at 2.5 mg/mL display similar trends as 
the 1mg/mL condition but much more pronounced with longer clotting half-times. The 
results from the polymerization data show that there is a balance between thrombin, 
microgel, and active fibrin knob peptide concentration in order to achieve clots without 
significantly altered polymerization rates. 
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Figure 9. Clotting Half-Time of Fibrin-Microgel Clots. Clotting half-time, measured 
as the time to reach ½ the normalized final turbidity value at 2 hours for various fibrin-
microgel clots polymerized with different thrombin concentrations. (A) clots polymerized 
with 1 mg/mL microgels (B) clots polymerized with 2.5 mg/mL microgels. * denotes 2.5 
mg/mL GPRPFPAC-microgel containing clots polymerized with 0.01 U/mL and 0.25 
U/mL thrombin that did not reach final turbidity at 2 hours.  
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4.3.3 Percent Clottable Protein in Fibrin-Microgel Clots 
The percent clottable protein in clots polymerized with 1 mg/mL microgels is 
shown in Figure 10A. The clots containing higher microgel concentrations polymerized 
with low concentrations of thrombin (< 0.1 U/mL) contain less clotted protein after 2 
hours of polymerization. At the 0.01 U/mL thrombin condition, the clots with 
GPSPFPAC-microgels have the least amount of clottable protein. It is uncertain why 
clots with the non-binding GPSPFPAC-microgels at 1 mg/mL have the highest overall 
turbidity, but the least amount of clottable protein compared to the fibrin control and 
other microgel conditions. GPRPFPAC-microgels at 1 mg/mL display similar amounts of 
percent clottable protein as the control at all thrombin concentrations. Clots with 
GPSPFPAC-microgels and unfunctionalized microgels have decreased amounts of 
protein at all thrombin concentrations. At the 0.25 U/mL thrombin condition, control 
clots have 95% clottable protein, GPRPFPAC-microgel containing clots have  
95%clottable protein, GPSPFPAC-microgel containing clots have 87% clottable protein, 
and unfunctionalized microgel containing clots have 89 % clottable protein. Formidable 
fibrin clots are considered to have at least 90% clottable protein, indicating that the 
presence of 1 mg/mL microgels approaches the acceptable limit for a formidable fibrin 
clot [15].  
 The percent clottable protein in clots polymerized with 2.5 mg/mL 
microgels is show in Figure 10B. For the 0.01-0.05 U/mL thrombin condition 
GPRPFPAC-microgel containing clots display the least amount of clottable protein 
because the clots have not reached final turbidity. From 0.075 U/mL and above, 
GPRPFPAC-microgels display similar trends as the 1 mg/mL condition with higher 
percent clottable protein that the other microgel conditions but containing slightly less 
percent clottable protein than the 1 mg/mL condition. At the 0.25 U/mL thrombin 
condition, control clots have 95% clottable protein, GPRPFPAC-microgel containing 
clots have 88%clottable protein, GPSPFPAC-microgel containing clots have 79% 
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clottable protein, and unfunctionalized microgel containing clots have 74 % clottable 
protein. This suggests that while the polymerization of GPRPFPAC-microgel containing 
clots is delayed, there is greater retention of protein in these clots than with other 
microgel containing clots. A similar trend of the least amount of percent clottable protein 
is observed for the 2.5 mg/mL GPSPFPAC-microgel condition at 0.01 U/mL thrombin. It 
is uncertain why the GPSPFPAC-microgels cause less protein retention in the final clot, 
but it is possible that the differences are because of alterations in macromolecular 
crowding due to differences in microgel charge, explained in the discussion. The general 
trend from the percent clottable protein data shows that at increasing microgel 




Figure 10. Percent Clottable Protein in Fibrin-Microgel Clots. Percentage of clottable 
protein was evaluated 2 hours after initiating polymerization for (A) 1 mg/mL microgel-
fibrin gels and (B) 2.5 mg/mL microgel-fibrin gels by back-calculating from the amount 
of soluble protein in the clot liquor of extracted clots, normalized against controls without 
thrombin.  
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4.3.4 Degradation of Fibrin-Microgel Clots 
 Clot degradation profiles of fibrin-microgel gels reveal that the clots degrade at a 
more rapid rate with increasing concentrations of microgels. The degradation of clots 
polymerized in the presence of 1 mg/mL microgels (Fig. 11A) shows that all clots 
containing microgels experience similar degradation rates. However, these rates are all 
slightly fast than the control as observed by the slopes of the curves. The degradation of 
clots polymerized in the presence of 2.5 mg/mL microgels (Fig. 11B) have similar 
characteristics as the 1 mg/mL condition where the degradation rates of all microgel 
containing clots are similar to one another. However, the 2.5 mg/mL microgel containing 
clots experience even quicker degradation rates than the 1 mg/mL condition. Because 
exogenous fibrinolysis is a diffusion dependent process, these results are not surprising 
considering that the volume filling microgels are expected to increase the porosity of the 
resulting network at increasing concentrations. Previous studies have shown similar 
trends, indicating that active knob peptide-PEG conjugates increased the effective 
diffusion coefficient through a fibrin network by 50-70% compared to control gels [15]. 





Figure 11. Turbidity Profiles of Fibrin-Microgel Clot Degradation. Absorbance 
measurements of clot degradation at 350 nm. (A) Exogeneous fibrinolysis of 1 mg/mL 
fibrin gels polymerized in the presence of 1 mg/mL microgels. (B) Exogeneous 
fibrinolysis of 1 mg/mL fibrin gels polymerized in the presence of 2.5 mg/mL microgels.  
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The percent soluble protein of fibrin-microgel clots after plasmin addition (Figure 
12) displayed similar results as the clot degradation profiles where the clots containing 
higher concentrations of microgels resulted in more rapid rates of degradation. For clots 
containing 1mg/mL microgels (Fig. 12A), similar percent soluble protein was observed 
for peptide-functionalized microgels and control clots. Although the initial amount of 
soluble protein for unfunctionalized microgel containing clots was higher, the 
degradation rate appears to be roughly the same for all groups. For clots containing 2.5 
mg/mL microgels (Fig. 12B), similar percent soluble protein was observed for peptide-
functionalized microgels and control clots. For clots containing 2.5 mg/mL 
unfunctionalized microgels, the initial amount of soluble protein was higher than other 
conditions. This is supported by the percent clottable protein data for 2.5 mg/mL 
unfunctionalized microgels polymerized with 0.25 U/mL thrombin showing the least 
amount of clottable protein compared to all other groups (Fig.10B). Additionally, these 
clots appear to degrade at a slightly faster rate within the first thirty minutes after plasmin 
addition. These results suggest that the presence of microgels alters fibrin network 




Figure 12. Percent Soluble Protein of Degrading Fibrin-Microgel Clots. (A) Percent 
soluble protein of 1 mg/mL fibrin clots polymerized in the presence of 1 mg/mL 
microgels. (B) Percent soluble protein of 1 mg/mL fibrin clots polymerized in the 
presence of 2.5 mg/mL microgels.  
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4.3.5 Fibrin-Microgel Clot Structure 
For a more direct evaluation of the type of structural changes to a fibrin network 
imposed by the presence of various peptide-microgel conjugates, 1 mg/mL clots were 
formed on glass slides using 10% Alexa Fluor 555-labeled fibrinogen to enable direct 
visualization and imaging of microgel containing clots using confocal microscopy (Fig. 
13). Clots containing 1 mg/mL unfunctionalized microgels appeared similar to the control 
but appeared to have slightly thinner fibers (Fig. 13B). Clots containing 1 mg/ml 
GPRPFPAC microgels had shorter more branched fibers than the fibrin control (Fig. 
13C), and the clots containing 1 mg/ml GPSPFPAC microgels had longer slightly thinner 
fibers than the GPRPFPAC-microgel condition, but appear more similar to the fibrin only 
condition but with thicker fibers than the control (Fig. 13D). With the unfunctionalized 
microgels, at increasing concentrations of microgels there appears to be increased fiber 
deposition compared to the control, but result in clots with highly thin fibers (Fig. 13B, E, 
H). This reduction in fiber thickness as compared to clot containing other types of 
microgels can explain why the final turbidity for unfunctionalized microgels is lower than 
the peptide-conjugated microgel conditions. GPRPFPAC-microgels at the 2.5 mg/mL 
concentration (Fig. 13F), display the same short, thicker, highly branched fibers and the 
GPSPFAC-microgels (Fig. 13G) have similar long-thicker fibers as the 1 mg/mL 
conditions but with reduced total fiber volume. Interestingly, at the highest microgel 
concentration containing 5 mg/mL GPRPFPAC-microgels (Fig. 13I), clots displayed 
nodular like structures with a greatly reduced total fiber volume than the control. One 
possible explanation for the nodular structures is the formation of fibrin-microgel 
aggregates where the local concentration of GPRPFPAC peptide available for association 
with fibrin holes is high. The 5 mg/ml GPSPFPAC-microgel condition (Fig. 13J) had a 
similar long-thick fiber structure as the 1mg/ml sample but with greatly reduced total 
fiber volume. One reason for the great difference in structure between the GPSPFPAC-
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microgels and the unfunctionalized microgels is possibly due to the charge difference of 
the microgels, which will be further explored in the discussion section.  
 
 
Figure 13. Confocal Z-stack Images of Fibrin Network Structure of Microgel 
Containing Clots. 1 mg/mL fibrin clots polymerized for 1 hour in the presence of 
peptide-labeled microgels at different concentrations (1 mg/ml, 2.5 mg/mL, and 5 mg/mL 
respectively). (A) Fibrin control. (B, E, H) Clots containing unfunctionalized microgels 
(C, F, I) Clots containing GPRPFPAC-microgels. (D, G, J) Clots containing GPSPFPAC-
microgels. Scale bar = 20um.  
 
4.4 Discussion 
The result from the turbidity readings and physical determination of fibrinogen-
triggered microgel assembly show that at the concentrations of microgels and fibrinogen 
and the peptide labeling density used, a colloidal gel was not able to form. Turbidity 
measurements are traditionally used to measure fiber network formation by the change in 
absorbance, but because our system does not depend on the formation of fibers, turbidity 
measurements are not the most suitable determination of the formation of a gel network. 
It is possible that at the concentrations of microgels, peptide, and fibrinogen we explored, 
the formation of clear or glassy micro-aggregates of fibrinogen coated microgels occur. A 
better detection system probing the interactions at the single molecule level, such as 
surface plasmon resonance (SPR) measurements to determine the kinetic binding 
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coefficients of fibrinogen with peptide-labeled microgels, needs to be explored. Dynamic 
light scattering techniques are also potential methods that can be used to probe the 
interactions of active knob peptide-labeled microgels with fibrinogen.  
The general trends from the fibrin polymerization data show that fibrin 
polymerized in the presence of microgels leads to overall greater final turbidity than the 
control, and at low thrombin concentrations, the rate of polymerization is delayed with 
increasing concentrations of microgels. GPRPFPAC-microgels have an increased delay 
in polymerization compared to other microgel conditions likely due to competition of 
active knob peptides with fibrin monomers for polymerization hole domains. In addition 
to the delayed polymerization rates, the amount of protein incorporated within a fibrin 
network is decreased with increasing concentrations of microgels. Correspondingly, the 
degradation assays of fibrin-microgel gels revealed that with increasing concentrations of 
microgels, the clots degraded at a more rapid rate. Confocal microscopy of microgel 
containing clots reveals greatly altered fibrin network structure. Peptide labeled-
microgels at increasing concentrations led to the formation of clots with highly open and 
porous networks, however, unfunctionalized microgels led to the formation of highly 
dense thin fiber meshes. The possible explanations for these trends are explored in the 
discussion sections below.   
 
4.4.1 Peptide Ligand Density  
 
As mentioned in the discussion of chapter 3, the low percent yield of peptide 
conjugation to microgels suggests a heterogeneous display of peptides off the surface of 
the microgel. Homogeneous conjugation and ligand density are crucial parameters 
determining interaction with fibrinogen and subsequent assembly of microgels into a 
colloidal gel. In order to better control peptide ligand density, an alternate conjugation 
approach should be used to greatly increase the percent yield. In order to determine the 
effect of ligand density on fibrinogen triggered colloidal assembly, microgels with up to 
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20% AAc groups available for conjugation should be used as an alternate to 5%AAc 
microgels. By varying the percent of acid groups conjugated with peptides from 0-100% 
functionalized, it will be possible to study the effect of ligand density on fibrinogen 
triggered microgel assembly in order to determine the optimal conjugation ratio for the 
rapid formation of a gel network. Although one possible downside to increasing the AAc 
concentration is that acrylic acid is extremely toxic to cells, and would not be the best 
material of choice for tissue engineering and regenerative medicine applications. 
Alternatively, more biocompatible materials might present a better option for peptide-
fibrinogen  knob:hole interaction facilitated hydrogel formation. The peptide density, the 
microgel concentration, and fibrinogen concentration are critical parameters that need to 
be optimized to ensure that fibrinogen molecules are more likely to bind between two 
microgels rather than binding to peptides on the same microgel in order to form a 
colloidal assembly.  
Fibrin polymerization in the presence of knob peptide-labeled microgels is 
dependent upon peptide, microgel, and thrombin concentration incorporated into the clot. 
It has been shown that at peptide concentrations of 100-fold molar excess to fibrinogen, 
that clot polymerization is inhibited, but at lower molar ratios fibrinogen is “pre-
engaged” through knob:hole interactions with the peptide to alter polymerization rates 
and the resulting composition and structure [32]. In the present study, fibrin 
polymerization assays used a 1mg/mL concentration of fibrinogen, which is 
approximately 2.94 mM. For the peptide-functionalized microgels at a 1 mg/mL 
concentration, a GPRPFPAC peptide concentration of 0.0145 mM per mg/mL of 
microgel and a GPSPFPFAC peptide concentration of 0.081 mM per mg/mL of microgel, 
correspond to a 1:200 mol ratio and 1:36 mol ratio of peptide to fibrinogen, respectively. 
These ratios are much lower than the 100:1 molar excess necessary for complete 
inhibition of clot formation, and suggest that free fibrinogen molecules not “pre-engaged” 
with active peptides are available for polymerizing into a fiber network.  
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In this study, the effect of microgel concentration on fibrin polymerization is 
dominant over the effect of peptide concentration. Based on previous studies of peptide: 
fibrinogen ratios on clot polymerization, it is possible that peptide ligand density 
equivalent to 100:1 molar ratio of peptide to fibrinogen for a 1 mg/mL concentration of 
microgels is sufficient to form a colloidal assembly, and enough to completely inhibit clot 
formation in the presence of clotting enzymes. In a previous paper on knob peptide-PEG 
conjugates, it was shown that tetravalent peptide-PEG conjugates in a 1:1 mol ratio of 
conjugate to fibrinogen had the greatest impact on fibrin matrix structure through the 
formation of a hybrid assembly where each peptide-PEG conjugate interacts with 4 
fibrinogen molecules, while each fibrinogen molecule has 4 holes available to participate 
in knob: hole interactions with other peptide-PEG conjugates [32]. This is a highly 
controlled system in which the molar ratios of peptide to fibrinogen can be readily 
adjusted based on conjugate valency. Future studies will aim to achieve this level of 
control with peptide-conjugated microgels by using better techniques for more efficient 
conjugation and investigating the effect of peptide ligand density on microgel interactions 
with fibrinogen.  
4.4.2 Microgel Shape 
While the round spherical shape of microgels did not greatly hinder the formation 
of a fibrin network, it did not assist in the formation of a fibrin network like we had 
hoped. The large difference in the shape and size of a microgel as compared to a 
fibrinogen molecule or fibrin monomer can be partially attributed to why we did not 
observe a decrease in the rate of fibrin polymerization. Future generations of knob 
peptide-polymer conjugates should take into consideration the shape and size scale of a 
typical fibrin monomer or fibrin fibers to assist in the formation of a fiber network. 
Exploring the use of polymers with rod-like shapes that resemble a fibrin fiber in shape 
and size might be the next step in rationally designing a knob peptide-polymer conjugate 
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that will assist in the self-assembly of fibrin fibers into a matrix. Based on the results of 
previous studies using peptide-PEG conjugates, it was suggested that the design of 
bisbivalent peptide-PEG linkers could favor the formation of course networks of thick 
fibers by pinning the ends of fibrinogen molecules together through knob: hole 
interactions to form protfibril-like structures, even in the absence of clotting enzymes 
[32]. Using a similar concept, Joel H. Collier’s group investigates the use of fibrin-based 
peptides and peptide-polymer conjugates for the formation of self-assembling 
viscoelastic hydrogels [31]. Short peptides from the coiled-coil domain of fibrin were 
conjugated to short PEG chains to form triblock peptide-PEG copolymers which then 
self-assemble in appropriate buffers to form a hydrogel. Similar self-assembly 
approaches utilizing the size and shape of native fibrin fibers should be explored for the 
next generation of knob peptide-polymer conjugates.  
  
4.4.3 Macromolecular Crowding 
 
The molecular weight of the macromolecule being polymerized into a fibrin 
network has a significant influence on the final structure and physical properties of the 
matrix. In one study, turbidity measurements and microscopy indicated that fibrin 
polymerized in the presence of low molecular weight heparin led to a more transparent 
rigid network with thin fibrin bundles, whereas the presence of unfractionated heparin 
resulted in opaque more porous networks with thick fibrin fibers [23]. For fibrin knob 
peptide conjugates, a biphasic effect of PEG chain length on fibrin polymerization was 
reported, where increased inhibition of fibrin polymerization occurred with active knob 
peptide-PEG conjugates from 0 to 5 kDa PEG, but above 5 kDa anticoagulant activity 
was diminished. For bivalent and tetravalent peptide-PEG conjugates, the results indicate 
that the presence of larger conjugates (7.5 kDa, 10 kDa, and 20 kDa GPRPx-PEG) 
favored the formation of stable, fine highly branched networks [32]. Additionally, the 
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formation of tight nodules of protein in GPRP-PEG conjugates but not in their respective 
controls is possibly attributed to clusters of GPRP-PEG-bound fibrin(ogen). This 
suggests that larger conjugates with long mobile PEG chain linkers between the peptide 
knobs interfere with lateral aggregation of fibrin protofibrils to form thick fibers [32], 
possibly due to non-directional orienting of fibrin molecules mediated by knob:hole 
interactions prior to thrombin addition [32]. Considering that the molecular weight of 
ULC microgels is expected to be between 10^6 and 10^9 g/mol [47, 48], the effect of 
microgel molecular weight is drastically multiplied as compared to PEG or heparin 
incorporation into a network. The expected result, based on these data is the formation of 
highly open and porous networks with very thick fibrin fibers or tight fiber clusters. This 
could explain why the final turbidity of fibrin polymerized in the presence of microgels is 
higher than the control and is further confirmed by the 5 mg/mL peptide-labeled microgel 
condition with the highly open network with thick fibers. However, the unfunctionalized 
microgel condition is an anomaly with its increased fiber deposition at higher 
concentrations. It is uncertain why this effect occurs, but it is possible that charge 
interactions play a large role in polymerization and fibrin deposition which will be further 
explored in the next discussion section.  
An explanation for the effect of microgel concentration and molecular weight on 
fibrin polymerization and structure can be partially attributed to macromolecular 
crowding (MMC). MMC is a biophysical concept in which inert macromolecules in 
solution occupy a significant volume of the medium and subsequently impact the 
biochemical reactions both in vivo and in vitro [63]. Inert macromolecules limit the space 
available for the reactant molecules by occupying space and creating dead space in 
between macromolecules that the reactant molecules are unable to pass through. Both 
macromolecule volume and dead space volume contribute to the exclude volume 
unavailable for reactant molecules, which result in two possible outcomes on the reactant 
molecule [64]. Firstly, the reduction in volume available for reactant interaction increases 
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the effective concentration of the reactant molecules and hence the thermodynamic 
activity of the reactant. Secondly, the diffusion rate and rate of encounter of the reactant 
molecules with one another is reduced [65]. The first will result in increased reaction 
rates, while the second will result in decreased reaction rates [66]. 
The effect of macromolecular crowding on extracellular matrix deposition has 
been explored by Krysten Van Vliet’s group, and their studies have shown that the 
addition of inert macromolecules was able to enhance collagen deposition in vitro by 
increasing the effective activities of two key enzymes involved in collagen deposition 
[67]. Another group found that either the presence of 500 kDa dextran sulfate or PEG 
increased the respective activities of purified procollagen C-proteinase and procollagen 
N-proteinase in vitro in a cell free system [68]. 
Based on these results, it is possible that our fibrin-microgel system creates a 
delicate balance between increased effective thrombin activity and reduced fibrin 
monomer-monomer association to form fibers. While turbidity measurements are not the 
best measure of increased effective activity of thrombin, the MMC effect of microgels 
inhibiting fibrin monomer association to form fibers is observed by the delayed 
polymerization rates with increasing concentrations of microgels. In addition to the effect 
of microgel MMC, the active knob peptide (GPRPFPAC)-microgels are not an inert part 
of the system, but actively compete with fibrinogen and fibrin monomers for knob holes, 
and further delay fibrin polymerization.  
One thing to note regarding the effect of macromolecular crowding, is that most 
molecular crowders are relatively solid masses, whereas ULC microgels are expected to 
be extremely porous due to their ultra-low degree of cross-linking and formation of a 
highly loose chain network. In order to determine the MMC effect of microgels, it will be 
important to determine the pore size and diffusivity of a microgel and examine whether 
ions, or even proteins can pass through an individual microgel. Microgel concentration, 
pH, ionic strength, and temperature are all critical conditions that will influence microgel 
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pore size and diffusivity. The degradation results suggest that diffusion is not hindered by 
the presence of microgels, but rather perpetuated by the microgels. Whether this is 
because of perturbations to a fibrin network with increased porosity due to volume 
exclusion by microgels, or whether this is due to direct diffusion through the microgels is 
uncertain. The mechanism of fibrin-microgel clot degradation needs to be investigated 
further in future studies.  
4.4.4 Microgel Surface Charge 
In addition to the size of the macromolecular crowder, surface charge of the 
macromolecule plays a large role in contributing to the excluded volume occupied by the 
crowder [64].  For anionic macromolecules, the surface charge adds a hydration shell 
around the molecule and contributes to steric exclusion due to like-charge repulsion 
increasing the effective volume of the crowder. The study by Raghunath et al, found a 
marked increase in collagen deposition with a negatively charged 200 kDa polysodium-4-
styrene sulfonate macromolecule. This difference in charge on MMC and ECM 
deposition possibly plays a large role in our fibrin-microgel system. Unfunctionalized 
microgels are functionalized with 5% AAc that carry a negative charge in physiological 
pH, while the GPSPFPAC peptide has a neutral charge, and the GPRPFPAC peptide has 
a positive charge of +1 [11]. While the percent of peptide conjugated to the microgels is 
low, it is possible that the slight differences in charge are sufficient to affect the 
polymerization of fibrin in different ways. What the exact effect or interaction of charged 
microgels with fibrinogen is unclear. In order to determine whether there is a true 
difference in charge between the microgels used in this study, unfunctionalized and 
peptide-functionalized microgels should be characterized for electrophoretic mobility to 
determine the overall charge of the microgel. In order to determine the influence of 
charged groups on fibrin polymerization, a range of 5%-20% AAc-microgels, and 5-20% 
aminopropyl methacrylate (which are positively charged at physiological pH) should be 
 55 








Upon vascular injury, fibrin polymerizes to form a fibrous gel that can withstand 
forces exerted by flowing blood and by embedded cells. They have remarkable physical 
properties by stiffening strongly when deformed and become increasingly resistant to 
further deformation [69]. Differences in clot stiffness can have significant physiological 
implications, in that highly rigid clots may be prone to thrombosis, while fragile clots 
may lead to premature lysis and re-opening of the wound [70]. Clot stiffness is thought to 
be strongly dependent on fibrin thickness and flexural stiffness, branchpoint density, 
fibrin concentration, and the presence of cross-linking agents such as Factor XIIIa [71]. 
However, due to strong enzymatic regulation, it is not possible to greatly increase gel 
rigidity starting from the natural components of fibrin clots at concentrations close to the 
physiological range [72]. At physiological concentrations (4.8mg/mL), fibrin hydrogels 
are soft and exhibit shear storage moduli on the order of 20-30Pascals [73].  
The addition of protein and polymer components during the polymerization of 
fibrin has been shown to greatly alter fibrin network structure and clot stiffness, while 
maintaining adequate biological properties for physiological processes like tissue 
regeneration and wound healing [21, 29]. Previous studies have shown the effect of fibrin 
knob peptide-conjugates on clot rigidity, suggesting that the presence of GPRP-PEG 
conjugates generally reduces the elastic modulus of a fibrin clot [32]. Interestingly, the 
loss tangent, reflecting the clot viscosity was not significantly perturbed. In another 
study, knob ‘A’-PEG conjugates were shown to decrease the complex moduli of fibrin by 
35% over controls, while knob ‘B’-PEG conjugates significantly enhance the complex 
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moduli [15]. These results raise questions about the role that various knob:hole 
interactions play in controlling the dynamics of fibrin assembly. Other attempts have 
been made to purposefully increase the clot rigidity of fibrin gels for tissue engineering 
applications. Simultaneous polymerization of polyethylene oxide (PEO) with fibrin 
resulted in interpenetrating networks with similar storage moduli as PEO networks alone 
or highly concentrated fibrin gels [21]. These hybrid gels also supported cell growth, 
demonstrating the feasibility of forming gels with enhanced clot rigidity but maintaining 
the biological function of fibrin.  
We hypothesize that the polymerization of fibrin in the presence of microgels will 
alter the final viscoelastic properties of the gel. We examined the shear and compressive 
properties of hybrid fibrin-microgel gels using fibrin concentrations of 4 and 8mg/mL 
protein, in order to observe gels with mechanical properties high enough to be accurately 
measured by the instruments used. Fibrin-microgel networks are expected to have 
improved bulk mechanical strength at lower fibrinogen concentrations, but because the 
formation of the fibrin-microgel assembly is due to multiple noncovalent interactions, it 
is possible that these microgels add a viscous component to the gel on the order of a cell 
encountering the network. Further studies will need to be performed to determine the 
effect of microgels on cell growth, matrix remodeling, and differentiation.  
5.2 Methods 
5.2.1 Materials 
Synthesized unfunctionalized pNIPAm microgels, GPRPFPAC-microgels, and 
GPSPFPAC-microgels, all described in Chapter 3, were used for these studies. The same 
chemicals were used as in section 4.2.1. for making assay buffers. Human fibrinogen 
FIB-3 and human α-thrombin were purchased from Enzyme Research Laboratories 
(South Bend, IN).   
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5.2.2 Bulk Rheology of Fibrin-Microgel Clots 
A Physica MCR 501 rheometer (Anton Paar, Hertford Herts, UK) was used to 
examine the viscoelastic properties of fibrin clots in the presence of microgels. For the 
fibrin control, the reaction components, fibrinogen and thrombin, were thoroughly mixed 
in HEPES +Ca buffer in a 9:1 volume ratio for a final volume of 200 ul, a final 
fibrinogen concentration of 8 mg/mL, and a final thrombin concentration of 1 U/mL. For 
samples containing microgels, the microgels were added to the fibrinogen solution and 
allowed to incubate at least 1 hour prior to experiments for a final concentration in the 
total clotting mixture of 1 and 2 mg/mL. After mixing in the thrombin solution, 180 uL of 
the clotting mixture was quickly transferred to the center of the bottom plate of a cone-
plate fixture set-up (2.014 cone angle, and 24.960 mm diameter). The cone was quickly 
lowered to the measurement position, and the sample was allowed to polymerize at room 
temperature for 2 hours before taking measurements. In order to prevent evaporation of 
the sample, dH2O was applied to a ring surrounding the exposed surfaces of the clots in a 
humidity chamber surrounding the cone-plate set up. 
Measurements were taken in oscillation mode at 0.5% constant strain over a 
frequency range of 0.05 and 50 Hz at 6 points/decade. The storage modulus (G’), a 
measure of the elastic energy stored during the deformation imposed by one oscillation of 
the rheometer, calculated by the Rheoplus software, was used as a measure of clot 
rigidity. The loss modulus (G”), the energy dissipated by the clot during deformation, 
was also recorded. Each condition was tested with at least 3 samples.    
5.2.3 Bulk Compression of Fibrin-Microgel Clots 
A Bose EnduraTEC
TM
 ELF 3200 Uniaxial Testing System (Bose Corporation 
ElectroForce, Eden Prairie, MN) was used to perform compression tests on 4 and 8 
mg/mL fibrin clots containing 1 and 2 mg/mL microgels. Clots were polymerized with 1 
U/mL thrombin in HEPES +Ca buffer for 2 hours in a silicone mold prior to taking 
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measurements. The silicone mold consisted of two layers of a CoverWell™ perfusion 
chamber gasket (Invitrogen, Frederick, Maryland), 9 mm in diameter and 2.5 mm deep, 
with the final dimensions of the samples being 9 mm in diameter and 5 mm in height. 
Strain at 10, 20, 30, 40, and 50% were applied at 1 Hz and all experiments were 
conducted at room temperature, with each condition being tested with at least 3 samples.  
5.3 Results  
5.3.1 Strength of Fibrin-Microgel Clots Under Shear 
Frequency sweeps of 8 mg/mL fibrin clots polymerized in the presence of 1 
mg/mL microgels at 0.5% and 0.46 Hz, showed only significant differences between the 
unfunctionalized microgel and control condition (Fig. 14A, B). The fibrin control and 
peptide-functionalized microgels exhibit similar storage moduli, however the addition of 
unfunctionalized microgels significantly increased the storage modulus of the bulk fibrin-
microgel clot (Fig. 14A). Interestingly the loss moduli was increased for all microgel 
containing clots compared to the control suggesting that microgels enhance the viscous 
component of an overall fibrin gel (Fig. 14B). For clots polymerized in the presence of 2 
mg/mL microgels, the gels exhibit generally lower storage and loss moduli than the 1 
mg/mL microgel conditions (Fig. 14C, D). The storage modulus of clots polymerized in 
the presence of 2.5 mg/mL unfunctionalized microgels is significantly greater than all 
other groups (Fig. 14C). The effect of an increase in the loss modulus due to microgel 
incorporation is lost in the 2.5 mg/mL microgel case where peptide-functionalized 
microgels exhibit similar loss moduli as the control (Fig. 14D). Interestingly, 
GPRPFPAC-microgels and the nonbinding control GPSPFPAC-microgels do not have 
significant differences in storage and loss moduli at either concentration of microgel 
incorporation.  
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Figure 14. Rheological Measurements of Fibrin-Microgel Clots. (A,B) Storage and 
loss modulus of 8 mg/mL fibrin clots polymerized in the presence of 1 mg/mL microgels 
at 0.46 Hz and 0.5% strain (C,D) Storage and Loss Modulus of 8 mg/mL fibrin clots 
polymerized in the presence of 2 mg/mL microgels at 0.46 Hz and 0.5%strain.* denotes 
p<0.05 relative to all groups, and # denotes p<0.05 relative to the control group.   
5.3.2 Strength of Fibrin-Microgel Clots Under Compression 
Although the uniaxial compression of fibrin-microgel clots was measured for 4 
and 8 mg/mL of fibrin, the results for 4 mg/mL microgels had higher error due to the 
detection limits of the instrument at low forces. Based on these results, only the data for 8 
mg/mL clots is presented below to show statistically significant differences. For clots 
polymerized in the presence of 1 mg/mL microgels, the presence of GPRPFPAC-
microgels significantly lowers the Young’s modulus of the bulk clot compared to clots 
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polymerized with unfunctionalized microgels alone (Fig. 15A). This decrease in clot 
rigidity is expected and has been shown previously with GPRP-PEG conjugates [5, 15, 
32]. Interestingly, at a concentration of 2.5 mg/mL microgels, unfunctionalized microgels 
significantly increase the Young’s modulus of the bulk fibrin-microgel clot compared to 
all other groups (Fig. 15B). At this concentration, the compressive strength of 
GPRPFPAC-microgel containing clots is comparable to the control and GPSPFPAC-
microgel containing clots.  
 
Figure 15. Uniaxial Compression Measurements of Fibrin-Microgel Clots. (A) 
Young’s modulus of 8 mg/mL fibrin clots polymerized in the presence of 1 mg/mL 
microgels. (B)Young’s modulus of 8 mg/mL fibrin clots polymerized in the presence of 2 
mg/mL microgels. * denotes p<0.05 relative to all groups.    
 62 
 
5.4 Discussion  
The most notable differences in the viscoelastic properties of fibrin-microgel gels 
occur with unfunctionalized microgels at a concentration of 2.5 mg/mL in the final clot. 
The results show a significant increase in the storage and Young’s modulus as compared 
to all other groups. It is uncertain why unfunctionalized microgels display these 
characteristics, but it is possible that microgel charge plays a central role in altering fibrin 
network structure and physical properties. Additionally, at 1 mg/mL microgel conditions, 
the loss moduli appear to be greater than the control clot suggesting that microgels add to 
the viscous component of the bulk gel. This carries potentially interesting questions for 
modulating the viscoelastic properties of fibrin matrices through the incorporation of 
microgels for determining cell fate. Native extracellular matrices are comprised of an 
elastic component such as collagen fibers, but are also embedded in a viscous component 
consisting of a variety of different glycosaminoglycans such as hyaluronic acid that 
promote angiogenesis. By being able to control both the bulk strength of the gel and the 
viscous components on the order of a cell interacting with the matrix, it might be possible 
to utilize these hybrid matrices for a better understanding of how cell fate is influenced 
by cell-matrix interactions.  
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CHAPTER 6 
CONCLUSIONS AND FUTURE WORK 
 
6.1 Conclusion 
In this study we explored the potential of fibrin knob peptide-displaying 
microgels to form a colloidal assembly in the presence of fibrinogen, and observed the 
effect of microgel incorporation on fibrin polymerization kinetics, network structure, and 
final physical properties of the matrix.  Chapter 3 demonstrated our ability to synthesize 
and functionalized ultra-low cross-linked microgels with fibrin knob peptides. The results 
from Chapter 4 indicate that the particular conditions that we explored for microgel 
concentration and peptide conjugation did not facilitate the rapid formation of a gel 
assembly. However, traditional tools for characterizing fibrin assembly may not be 
applicable to microgel-fibrinogen interactions, and other characterizing tools need to be 
explored to determine the dynamic interaction of active knob peptide-displaying 
microgels with fibrinogen.  
In regards to fibrin polymerization, we were able to discern distinct trends despite 
stark differences in the properties of a fibrin network in the presence of unfunctionalized 
microgels and peptide conjugated microgels. Chapter 4 demonstrated the effect of 
microgels on polymerization rate, with increasing concentrations of microgels impeding 
fibrin network assembly and protein incorporation at low thrombin concentrations, while 
increasing the network’s susceptibility to fibrinolysis. In Chapter 5 we explored the 
resulting mechanical properties of a hybrid fibrin-microgel gel, and revealed that 
microgels significantly alter the viscoelastic properties of a bulk gel with various effects 
at different concentrations.  
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The results from these studies introduce several questions about the interactions 
of microgels with fibrin(ogen), including the effect of peptide ligand density, microgel 
size and porosity, the effect of macromolecular crowding on fibrin assembly, and 
microgel charge interactions with fibrin. Exploring these effects in more detailed studies 
will help clarify our understanding about microgel interaction with fibrinogen and 
microgel interaction with a forming matrix.  
6.2 Investigating Angiogenesis Properties of Hybrid Clots  
In addition to understanding the influence of microgels on fibrin polymerization 
and structure, for viable applications as a hemostatic or tissue engineered construct, it 
will be necessary to probe the effect of microgel incorporation into a fibrin network on 
cell fate. Several parameters such as microgel concentration, microgel functionality with 
different peptide or protein displaying moeties, microgel charge, and the influence of the 
volume phase transition of the microgels in physiological conditions are expected to play 
a key role in determining cell fate.  
Fibrin-microgel networks with heterogenous clot structure, and distinct 
mechanical properties present unique architectures in which to study cell growth and 
differentiation. As previously described in earlier discussion sections, because the 
microgels are not physically cross-linked into a fibrin network, the colloidal assembly of 
microgels within a fibrin matrix have the potential of significantly altering the 
viscoelasticity of fibrin networks on both the macroscopic and microscopic scale. By 
adding a polymer component to a fibrin gel, the general trend shows an increase in 
network stiffness, however at the size scale of a cell penetrating through a fibrin-microgel 
matrix, the noncovalent microgel assembly has the possibility of presenting a viscous 
component to the network thereby allowing cells to “push” through the microgel 
assembly and possibly enhancing the angiogenic potential of fibrin-microgel gels. These 
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fibrin-microgel networks may provide an interesting system to study the influence of cell-
matrix interactions on cell fate.  
We have established several angiogenesis models, including a microvessel 
construct model [15] and a HUVEC +fibroblast model that may be used to determine the 
angiogenesis potential of hybrid-microgel networks. Previous studies of cell growth in 
thermogelable pNIPAm microgel dispersions alone, showed that acrylic acid content had 
an adverse effect on cell culturing, at concentrations of AAc up to 5% [74]. While the 
presence of fibrin may alter these characteristics of a hybrid gel, the potential effects of 
AAc toxicity need to be taken into consideration in the next generation of peptide-
microgel constructs for more optimal control of fibrin matrix properties for tissue 






























FIBRIN POLYMERIZATION IN THE PRESENCE OF 
FLUORESCENTLY LABELED MICROGELS 
 
Based on confocal images of microgel incorporated fibrin networks in Section 
4.3.4, it was suspected that the areas not occupied by fibrin fibers are filled with space 
filling microgels. In order to visualize the interaction of microgels in a fibrin network, 
pNIPAm microgels were synthesized containing 0.1 M 4-acrylamidofluorescein (AFA) 
following the same synthesis protocol described in Section 3.2.2, but with the addition of 
0.1 M AFA to the solution prior to initiation. 1 mg/mL and 2 mg/mL fibrin clots 
containing 0.25 mg/mL, 0.5 mg/mL and 1 mg/mL AFA-microgels were prepared 
similarly to the samples in Section 4.2.5 and imaged using the Zeiss 510 laser scanning 
confocal microscope (Carl Zeiss, Thornwood, NY). The AFA-microgels were excited 
using the Ar 488 laser, and the Alexa Fluor-555 labeled fibrinogen was observed using 
excitation by the He 543 laser under the multitracking mode. A 10 um Z-stack of 20 (0.53 
um) slices under the 63X objective was captured for reconstructing the 3D fibrin-
microgel network structure.  
By observing the compiled 3D Z-stack images in Figure 16, it is clear to see that 
the microgels act as space filling colloids by occupying the regions in-between fibrin 
fibers. However, upon closer observation, by taking time series images of the fibrin-
microgel network taken at 1 second intervals over the course of 10 seconds at a fixed 
focal plane, it is evident that the microgels are not physically crosslinked into the fibrin 
matrix, but diffuse throughout the open regions of the fibrin network (Figures 17 -22 
found in separate files from thesis). At higher concentrations of microgels this diffusion 
is impeded by an increased number of microgel-microgel contacts. In addition to 
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microgel concentration dependent diffusion, at a higher protein concentration of 2 
mg/mL, microgel diffusion is constrained by a denser fibrin matrix.  
 
Figure 16. Confocal Z-stack Images of Fibrin Polymerized in the Presence of AFA-
microgels. (A-D) 1 mg/mL fibrin. (E-H) 2 mg/mL fibrin. (A,E) fibrin controls. (B,F) 
0.25 mg/mL AFA-microgels. (C,G) 0.5 mg/mL AFA-microgels (D,H) 1 mg/mL AFA-
microgels. Scale bar = 20 um.  
 
In order to determine if positive binding GPRPPFAC-microgels would be 
effectively crosslinked into the network by being incorporated into fibrin fibers through 
knob:hole interactions, GPRPFPAC peptides were conjugated to (2.5%AAc, 2.5% PEG-
CH3)-AFA-microgels and polymerized into a fibrin-microgel clot. Z-stack confocal 
images in Figure 23 show an altered fibrin structure in the presence of GPRPFPAC-
conjugated microgels compared to controls. Short and thick, highly branched structures 
are exhibited, similar to fibrin polymerized in the presence of nonfluorescently labeled 
GPRPFPAC-microgels. However, time series confocal images of a single focal plane, 
show that GPRPFPAC-conjugated microgels do not bind to a fibrin matrix, but also 
diffuse throughout the fiber network like unfunctionalized microgels (Fig. 24 found in 
separate file from thesis). A number of different factors might be the cause of this, 
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A B C 
including heterogeneous ligand density that does not allow for the formation of sufficient 
peptide-fibrinogen interactions to stabilize the microgel within the network and 
noncovalent knob:hole interactions that do not permit permanent physical cross-linking 
of the microgel into the network. 
 
Figure 23: Confocal Z-stack images of GPRPFPAC-AFA Microgel Containing 
Clots. (A) 1 mg/mL fibrin control (B) 0.5 mg/mL AFA microgels (C) 0.5 mg/mL 
GPRPFPAC-AFA microgels. Scale bar = 20 um.  
 
The conjugation strategy for peptide-AFA-microgels was altered slightly due to 
the decreased stability of fluorescently labeled microgels modified with peptides. Several 
approaches for peptide conjugation to various types of fluorescently labeled 5% pNIPAm 
ULC microgels yielded microgels that either resulted in a loss of fluorescence upon the 
conjugation of peptides or permanent aggregation upon lyophilization of the peptide-
microgel conjugate. It is unclear why there might be a loss of fluorescence upon the 
conjugation of peptides to fluorescently labeled microgels. Some possibilities that have 
been discussed are that the peptides react with the fluorophores in a forster resonance 
energy transfer reaction (FRET) or that free radicals remaining within the microgel 
solution cause quenching upon the addition of peptides. Further investigation of the 
optimal conjugation conditions using ultra-low cross-linked microgels needs to be 
explored. As for the problems regarding lyophilization, GPRPFPAC- peptides have an 
overall charge of +1, which might interact with residual AAc groups on weakly stable 
fluorescently labeled ULC microgels. While they do not aggregate in solution, upon 
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lyophilization the charge interactions between peptides and AAc groups and polymer 
chain entanglement between microgels causes permanent aggregation. The energy 
required to resuspend the microgels in solution is too great to overcome the charge 
interactions of the peptide-AAc groups and polymer chain entangling between microgels.   
In addition to problems with peptide conjugation, the use of fluorescently labeled 
microgels, renders them hard to characterize. The background fluorescence of AFA-
microgels interferes with the CBQCA fluorescence-based peptide quantitation assay, 
impeding accurate peptide determination. In order to disconnect the effect of microgels 
on characterizing the peptide conjugated, using a peptide cleavable linker to conjugate 
the peptides to the microgels might be a better approach worth exploring in future studies 
using fluorescently labeled microgels.  
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